اوبديفو 40مجم/4مل امبول حقن وريدي

ما هو دواء اوبديفو 40مجم/4مل امبول حقن وريدي

جرعة دواءاوبديفو 40مجم/4مل امبول حقن وريدي

يستعمل دواء اوبديفو 40مجم/4مل امبول حقن وريديopdivo 40 mg/4 ml i.v. vial antineoplastic antineoplastic

indications - -1.for patients with previously treated metastatic non-small cell lung cancer. -2.for metastatic melanoma patients. -3.for advanced renal cell carcinoma patients who received prior anti-angiogenic therapy. -4.for patients with recurrent or metastatic squamous cell carcinoma of the head and neck on or after platinum-based therapy . -5.for the adjuvant treatment of patients with melanoma with involvement of lymph nodes or metastatic disease who have undergone complete resection. -6.for patients with hepatocellular carcinoma (hcc) previously treated with sorafenib. -7.for patients with previously treated locally advanced or metastatic urothelial carcinoma who have disease progression during or following platinum-based chemotherapy. -8.for patients (=12 years) with msi-h/dmmr metastatic colorectal cancer (mcrc) that has progressed following treatment with a fluoropyrimidine oxaliplatin and irinotecan. -9.for adults with relapsed or progressed chl after 3 or more lines thrpy

تركيبة دواءاوبديفو 40مجم/4مل امبول حقن وريديopdivo 40 mg/4 ml i.v. vial

يتركب هذا الدواء من :nivolumab